Lucas S Ryan Selected Research

Erythrosine (Erythrosin)

7/2022	Correction to "Dark Dynamic Therapy: Photosensitization without Light Excitation Using Chemiluminescence Resonance Energy Transfer in a Dioxetane-Erythrosin B Conjugate".
1/2022	Dark Dynamic Therapy: Photosensitization without Light Excitation Using Chemiluminescence Resonance Energy Transfer in a Dioxetane-Erythrosin B Conjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucas S Ryan Research Topics

Disease

2	Photosensitivity Disorders (Photodermatitis) 07/2022 - 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hypoxia (Hypoxemia) 01/2019

Drug/Important Bio-Agent (IBA)

2	Erythrosine (Erythrosin)IBA 07/2022 - 01/2022
1	Photosensitizing Agents (Photosensitizers)IBA 01/2022
1	NitroreductasesIBA 01/2022
1	Phenol (Carbolic Acid)FDA Link 01/2022
1	Singlet OxygenIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2019
1	EstersIBA 01/2019

Therapy/Procedure

2	Therapeutics 07/2022 - 01/2022